Currency in INR
| Earnings estimate | Current qtr. (Sep 2021) | Next qtr. (Dec 2021) | Current year (2022) | Next year (2023) |
|---|
| No. of analysts | 3 | 3 | 31 | 31 |
| Avg. Estimate | 6.83 | 6.91 | 28.73 | 32.68 |
| Low estimate | 6.18 | 6.41 | 25.1 | 27.81 |
| High estimate | 7.22 | 7.22 | 33.5 | 38.4 |
| Year ago EPS | N/A | N/A | N/A | 28.73 |
| Revenue estimate | Current qtr. (Sep 2021) | Next qtr. (Dec 2021) | Current year (2022) | Next year (2023) |
|---|
| No. of analysts | 3 | 3 | 34 | 33 |
| Avg. Estimate | 93.98B | 95.83B | 379.28B | 416.16B |
| Low estimate | 92.45B | 93.76B | 358.43B | 381.65B |
| High estimate | 96.49B | 97.64B | 398.31B | 443.69B |
| Year ago sales | N/A | N/A | N/A | 379.28B |
| Sales growth (year/est) | N/A | N/A | N/A | 9.70% |
| Earnings history | Invalid Date | Invalid Date | Invalid Date | 30/06/2021 |
|---|
| Est. EPS | N/A | N/A | N/A | 6.43 |
| Actual EPS | N/A | N/A | N/A | 8.62 |
| Difference | N/A | N/A | N/A | 2.19 |
| Surprise % | N/A | N/A | N/A | 34.10% |
| EPS trend | Current qtr. (Sep 2021) | Next qtr. (Dec 2021) | Current year (2022) | Next year (2023) |
|---|
| Current estimate | 6.83 | 6.91 | 28.73 | 32.68 |
| 7 days ago | 0 | 0 | 0 | 0 |
| 30 days ago | 0 | 0 | 0 | 0 |
| 60 days ago | 0 | 0 | 0 | 0 |
| 90 days ago | 0 | 0 | 0 | 0 |
| EPS revisions | Current qtr. (Sep 2021) | Next qtr. (Dec 2021) | Current year (2022) | Next year (2023) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | 2 | 1 |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | SUNPHARMA.NS | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | N/A | N/A | N/A | N/A |
| Next year | 13.70% | N/A | N/A | N/A |
| Next 5 years (per annum) | 33.30% | N/A | N/A | N/A |
| Past 5 years (per annum) | -8.93% | N/A | N/A | N/A |
